(Q79208787)
Statements
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study (English)
Carmen A Puliafito
Andrew A Moshfeghi
Philip J Rosenfeld
Stephan Michels
Erin N Marcus
Anna S Venkatraman